…until now.The answer is…..you don’tHow do you know
that the medications you take
or the lifestyle changes you are painstakingly making
are directly improving
your cardiovascular health?

Introducing the SmartCuffTM

A simple noninvasive device to monitor your blood vessel health anywhere, anytime

1
2
3
1

SmartCufftm monitor touch screen

2

FDA approved Welch Allyn cuff (3 sizes are included)

3

FDA approved oximeter (3 sizes are included)

Non-invasive

Low-risk class II device

Non-imaging and non-radiating

Can be used on pregnant women and children

Simple and easy

Does not need a physician to perform the test

Quick

6-minute test with immediate results (Point-of-Care testing)

Fits workflow

Portable device means patients don’t need to leave the exam room for testing

Click-charge recurring revenue model

By selling tests, not devices and using existing billing codes and direct patient pay models

700+

Patients Tested

1200+

tests performed

34

patents in 17 countries

20

Test sites

$12 Million

Raised inc. $700K in gov grants

Rediscover your heart health

Did you know?

There are 60,000 miles of blood vessels in the human body.  Sewn end-to-end, they would wrap around the world — twice.  Every millimeter of every blood vessel is lined with a single layer of cells (endothelial cells) known as the endothelial lining or simply, the endothelium.  The total surface area of the endothelium is 4,000-7,000 m2. To put this into perspective, the surface area of a standard, professional-sized tennis court is 261 m2. The endothelium is the largest organ in the human body! Thus, having a window into the health of one’s endothelium is a powerful tool to assess vascular health.

Our journey

About us

Our mission is to empower everyone to be able to check their vascular health anywhere, anytime. Our company began as an idea on paper. A concept that could shift the paradigm of how cardiovascular disease could be detected and managed using a metric that the medical community has known about for more than 100 years.

Since our founding, we have designed, prototyped and patented a device that can measure vascular health with a push of a button. We have partnered with top 5 ranked medical centers as well as clinicians and business leaders at Harvard, Stanford, Duke, UCLA, Goldman Sachs, Morgan Stanley, Morganthaler, PwC, Pfizer and AstraZeneca to prepare this product for the final stages of the FDA approval process.

Meet the team

Cordex Systems was founded by two Executive MBA students at UCLA Anderson School of Business, Dr. Kathy Magliato, MD (a cardiac surgeon) and Dr. Michael Whitt, PhD (a bioengineer).  The team and board of directors includes MBAs and professors from Wharton, Harvard, Stanford, Duke, and individuals with decades of experience leading successful companies in healthcare and extensive M&A experience.

News

Dr. Michael Whitt Wins MLK Legacy Award

Professor Michael Whitt speaks about his passions for sports and supporting the Cal Poly community while accepting the MLK Legacy Award in January.
© Copyright - Cordex Systems - This device is not yet FDA approved.